376 related articles for article (PubMed ID: 37274127)
1. The mTOR signaling pathway in cardiac aging.
Dai DF; Kang P; Bai H
J Cardiovasc Aging; 2023; 3(3):. PubMed ID: 37274127
[TBL] [Abstract][Full Text] [Related]
2. TOR Signaling Pathway in Cardiac Aging and Heart Failure.
Daneshgar N; Rabinovitch PS; Dai DF
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33513917
[TBL] [Abstract][Full Text] [Related]
3. TGFB-INHB/activin signaling regulates age-dependent autophagy and cardiac health through inhibition of MTORC2.
Chang K; Kang P; Liu Y; Huang K; Miao T; Sagona AP; Nezis IP; Bodmer R; Ocorr K; Bai H
Autophagy; 2020 Oct; 16(10):1807-1822. PubMed ID: 31884871
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II blockade: how its molecular targets may signal to mitochondria and slow aging. Coincidences with calorie restriction and mTOR inhibition.
de Cavanagh EM; Inserra F; Ferder L
Am J Physiol Heart Circ Physiol; 2015 Jul; 309(1):H15-44. PubMed ID: 25934099
[TBL] [Abstract][Full Text] [Related]
5. mTOR Hyperactivation by Ablation of Tuberous Sclerosis Complex 2 in the Mouse Heart Induces Cardiac Dysfunction with the Increased Number of Small Mitochondria Mediated through the Down-Regulation of Autophagy.
Taneike M; Nishida K; Omiya S; Zarrinpashneh E; Misaka T; Kitazume-Taneike R; Austin R; Takaoka M; Yamaguchi O; Gambello MJ; Shah AM; Otsu K
PLoS One; 2016; 11(3):e0152628. PubMed ID: 27023784
[TBL] [Abstract][Full Text] [Related]
6. mTOR signaling in aging and neurodegeneration: At the crossroad between metabolism dysfunction and impairment of autophagy.
Perluigi M; Di Domenico F; Butterfield DA
Neurobiol Dis; 2015 Dec; 84():39-49. PubMed ID: 25796566
[TBL] [Abstract][Full Text] [Related]
7. Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship.
Jhanwar-Uniyal M; Wainwright JV; Mohan AL; Tobias ME; Murali R; Gandhi CD; Schmidt MH
Adv Biol Regul; 2019 May; 72():51-62. PubMed ID: 31010692
[TBL] [Abstract][Full Text] [Related]
8. Growing knowledge of the mTOR signaling network.
Huang K; Fingar DC
Semin Cell Dev Biol; 2014 Dec; 36():79-90. PubMed ID: 25242279
[TBL] [Abstract][Full Text] [Related]
9. The Multifaceted Role of Nutrient Sensing and mTORC1 Signaling in Physiology and Aging.
Fernandes SA; Demetriades C
Front Aging; 2021; 2():707372. PubMed ID: 35822019
[TBL] [Abstract][Full Text] [Related]
10. Mammalian target of rapamycin signaling in cardiac physiology and disease.
Sciarretta S; Volpe M; Sadoshima J
Circ Res; 2014 Jan; 114(3):549-64. PubMed ID: 24481845
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic Target of Rapamycin Signaling Activation Antagonizes Autophagy To Facilitate Zika Virus Replication.
Sahoo BR; Pattnaik A; Annamalai AS; Franco R; Pattnaik AK
J Virol; 2020 Oct; 94(22):. PubMed ID: 32878890
[TBL] [Abstract][Full Text] [Related]
12. RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells.
Gordon BS; Kazi AA; Coleman CS; Dennis MD; Chau V; Jefferson LS; Kimball SR
Cell Signal; 2014 Mar; 26(3):461-7. PubMed ID: 24316235
[TBL] [Abstract][Full Text] [Related]
13. Mammalian target of rapamycin (mTOR) as a potential therapeutic target in various diseases.
Kaur A; Sharma S
Inflammopharmacology; 2017 Jun; 25(3):293-312. PubMed ID: 28417246
[TBL] [Abstract][Full Text] [Related]
14. mTOR as Regulator of Lifespan, Aging, and Cellular Senescence: A Mini-Review.
Weichhart T
Gerontology; 2018; 64(2):127-134. PubMed ID: 29190625
[TBL] [Abstract][Full Text] [Related]
15. Monitoring mammalian target of rapamycin (mTOR) activity.
Ikenoue T; Hong S; Inoki K
Methods Enzymol; 2009; 452():165-80. PubMed ID: 19200882
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous loss of TSC1 and DEPDC5 in skeletal and cardiac muscles produces early-onset myopathy and cardiac dysfunction associated with oxidative damage and SQSTM1/p62 accumulation.
Cho CS; Kim Y; Park SR; Kim B; Davis C; Hwang I; Brooks SV; Lee JH; Kim M
Autophagy; 2022 Oct; 18(10):2303-2322. PubMed ID: 34964695
[TBL] [Abstract][Full Text] [Related]
17. Regulation and metabolic functions of mTORC1 and mTORC2.
Szwed A; Kim E; Jacinto E
Physiol Rev; 2021 Jul; 101(3):1371-1426. PubMed ID: 33599151
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of mTORC1 but not mTORC2 protects against human disc cellular apoptosis, senescence, and extracellular matrix catabolism through Akt and autophagy induction.
Kakiuchi Y; Yurube T; Kakutani K; Takada T; Ito M; Takeoka Y; Kanda Y; Miyazaki S; Kuroda R; Nishida K
Osteoarthritis Cartilage; 2019 Jun; 27(6):965-976. PubMed ID: 30716534
[TBL] [Abstract][Full Text] [Related]
19. Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2.
Feldman ME; Apsel B; Uotila A; Loewith R; Knight ZA; Ruggero D; Shokat KM
PLoS Biol; 2009 Feb; 7(2):e38. PubMed ID: 19209957
[TBL] [Abstract][Full Text] [Related]
20. Selective interference of mTORC1/RAPTOR protects against human disc cellular apoptosis, senescence, and extracellular matrix catabolism with Akt and autophagy induction.
Ito M; Yurube T; Kakutani K; Maeno K; Takada T; Terashima Y; Kakiuchi Y; Takeoka Y; Miyazaki S; Kuroda R; Nishida K
Osteoarthritis Cartilage; 2017 Dec; 25(12):2134-2146. PubMed ID: 28888905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
